Amedisys Inc. buy Credit Suisse Group AG
Start price
28.02.23
/
50%
€85.50
Target price
28.02.24
€108.15
Performance (%)
-0.58%
End price
29.02.24
€85.00
Summary
This prediction ended on 29.02.24 with a price of €85.00. The BUY prediction by Credit_Suisse_Group_ for Amedisys Inc. closed nearly unchanged. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amedisys Inc. | - | - | - | - |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% | 43.350% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% | 72.418% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% | 43.435% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% | 54.983% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $115.00 price target on the stock.
Ratings data for AMED provided by MarketBeat
In the thread Trading Amedisys Inc.
Die von Credit_Suisse_Group_ gewählte maximale Laufzeit wurde überschritten